Cardiac troponin i for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

American Heart Journal

Volumn 169, Issue 2, 2015, Pages 257-265.e1

  Hall, Trygve Sørdahl ^a,b   Hallén, Jonas ^c   Krucoff, Mitchell W ^d   Roe, Matthew T ^d   Brennan, Danielle M ^e   Agewall, Stefan ^b,f   Atar, Dan ^b,f   Lincoff, A Michael ^e  

^a LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Medical Affairs   (Norway)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN I; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

AREA UNDER CURVE; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84921886384     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.10.015     Document Type: Article

References (26)

1. E. Wu, J.T. Ortiz, and P. Tejedor Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736
2. J. Hallen, P. Buser, and J. Schwitter Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction Am J Cardiol 104 2009 1472 1477
3. H. Steen, E. Giannitsis, and S. Futterer Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function J Am Coll Cardiol 48 2006 2192 2194
4. H. Boden, T.A. Ahmed, and M.A. Velders Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention Am J Cardiol 111 2013 1387 1393
5. J. Hallen, J.K. Jensen, and M.W. Fagerland Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction Heart 96 2010 1892 1897
6. S. Chia, F. Senatore, and O.C. Raffel Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 415 423
7. P. Ohlmann, L. Jaquemin, and O. Morel Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction Am Heart J 152 2006 1161 1167
8. J. Hallen Troponin for the estimation of infarct size: what have we learned? Cardiology 121 2012 204 212
9. DELTA MI Investigators Investigators. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896
10. A.M. Lincoff, M. Roe, and P. Aylward Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial Eur Heart J 35 2014 2516 2523
11. D. Uettwiller-Geiger, A.H. Wu, and F.S. Apple Multicenter evaluation of an automated assay for troponin I Clin Chem 48 2002 869 876
12. K.M. Eggers, B. Lagerqvist, and P. Venge Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality Circulation 116 2007 1907 1914
13. R.T. Vollmer, R.H. Christenson, and K. Reimer Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function Am J Clin Pathol 100 1993 293 298
14. A.T. Turer, K.W. Mahaffey, and D. Gallup Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction Curr Control Trials Cardiovasc Med 6 2005 12
15. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
16. S. Masson, R. Latini, and I.S. Anand Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
17. T.J. Wang, J.C. Evans, and E.J. Benjamin Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
18. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
19. M.J. Pencina, R.B. D'Agostino Sr., and R.B. D'Agostino Jr. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
20. R.A. Byrne, G. Ndrepepa, and S. Braun Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 106 2010 1212 1217
21. A.K. Hassan, S.C. Bergheanu, and H. Hasan-Ali Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention Am J Cardiol 103 2009 779 784
22. K. Kurz, C. Schild, and P. Isfort Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction Clin Res Cardiol 98 2009 94 100
23. A. Azakie, J.R. Fineman, and Y. He Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo J Thorac Cardiovasc Surg 132 2006 1262 1271
24. R. Fernandez-Jimenez, P. Lopez-Romero, and A. Suarez-Barrientos Troponin release overestimates infarct size in presence of left ventricular hypertrophy J Am Coll Cardiol 60 2012 640 641
25. M. Zaninotto, M.M. Mion, and E. Novello Precision performance at low levels and 99th percentile concentration of the Access AccuTnl assay on two different platforms Clin Chem Lab Med 47 2009 367 371
26. F.S. Apple Counterpoint: standardization of cardiac troponin I assays will not occur in my lifetime Clin Chem 58 2012 169 171